Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Eris Lifesciences has notified the stock exchanges about a credit rating update issued by India Ratings & Research. The filing itself does not disclose the specific rating or whether it has been upgraded, downgraded, or placed on watch. The company has merely confirmed receiving the rating update and stated that the details are available in the India Rating Press Release. No new credit facility, debt restructuring, or other rating-related actions are mentioned in this document.
Likely market impact
Since the actual rating action is not disclosed in this filing, shareholders need to check the India Ratings & Research press release for details to understand if the rating change is positive or negative for the stock.